|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02675 EDGE MEDICAL-B
Nominal 
35.500 -0.200 (-0.560%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Turnover | 319,316 | 113.757% | 455,715 | 159,994 | 48,042 |
| Cost of Sales | (114,688) | 106.522% | (155,063) | (61,917) | (19,576) |
| Gross Profit | 204,628 | 118.037% | 300,652 | 98,077 | 28,466 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (15,223) | -- | 13,359 | 21,214 | 36,974 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (10) | -85.294% | (91) | 0 | 0 | |
| Profit / (Loss) before Taxation | (19,254) | -78.382% | (88,607) | (218,509) | (212,869) | |
| Taxation | 0 | -- | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (19,254) | -78.387% | (88,607) | (218,509) | (212,869) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (12,734) | 529.461% | (4,892) | (4,359) | (4,379) |
| Depreciation & Amortisation | 13,495 | -1.969% | 25,630 | 28,279 | 18,877 |
| Directors' Emoluments | -- | -- | -- | 5,095 | 4,570 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | |
| EPS (cts) | -5.000 | -80.000% | -25.000 | -61.000 | -59.000 |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.540) | (0.624) | (0.890) |
| NBV per share ($) | 5.922 | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 11/09/2026 14:26 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -19,254 |
| %Change | -78.387% |
| EPS / (LPS) | RMB -0.050 |
| NBV Per Share (¥) | RMB 5.922 |